These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 29957056)

  • 41. Long Non-Coding RNA LOC648987 Promotes Proliferation and Metastasis of Renal Cell Carcinoma by Regulating Epithelial-Mesenchymal Transition.
    Su Y; Zhou L; Yu Q; Lu J; Liu W
    Technol Cancer Res Treat; 2021; 20():1533033821997834. PubMed ID: 33858283
    [TBL] [Abstract][Full Text] [Related]  

  • 42. SOX7 suppresses endothelial-to-mesenchymal transitions by enhancing VE-cadherin expression during outflow tract development.
    Jiang X; Li T; Li B; Wei W; Li F; Chen S; Xu R; Sun K
    Clin Sci (Lond); 2021 Mar; 135(6):829-846. PubMed ID: 33720353
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma.
    Morris MR; Ricketts CJ; Gentle D; McRonald F; Carli N; Khalili H; Brown M; Kishida T; Yao M; Banks RE; Clarke N; Latif F; Maher ER
    Oncogene; 2011 Mar; 30(12):1390-401. PubMed ID: 21132003
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sox7 Is an independent checkpoint for beta-catenin function in prostate and colon epithelial cells.
    Guo L; Zhong D; Lau S; Liu X; Dong XY; Sun X; Yang VW; Vertino PM; Moreno CS; Varma V; Dong JT; Zhou W
    Mol Cancer Res; 2008 Sep; 6(9):1421-30. PubMed ID: 18819930
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Functional epigenomics approach to identify methylated candidate tumour suppressor genes in renal cell carcinoma.
    Morris MR; Gentle D; Abdulrahman M; Clarke N; Brown M; Kishida T; Yao M; Teh BT; Latif F; Maher ER
    Br J Cancer; 2008 Jan; 98(2):496-501. PubMed ID: 18195710
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Carbonic anhydrase 10 functions as a tumor suppressor in renal cell carcinoma and its methylation is a risk factor for survival outcome.
    Li Q; Zhang L; Zhang Z; Fan Y; Zhang Q
    Urol Oncol; 2022 Apr; 40(4):168.e1-168.e9. PubMed ID: 34980544
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The regulation of SOX7 and its tumor suppressive role in breast cancer.
    Stovall DB; Wan M; Miller LD; Cao P; Maglic D; Zhang Q; Stampfer MR; Liu W; Xu J; Sui G
    Am J Pathol; 2013 Nov; 183(5):1645-1653. PubMed ID: 24012678
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Silencing of CCND2 by Promoter Aberrant Methylation in Renal Cell Cancer and Analysis of the Correlation between CCND2 Methylation Status and Clinical Features.
    Wang L; Cui Y; Zhang L; Sheng J; Yang Y; Kuang G; Fan Y; Zhang Q; Jin J
    PLoS One; 2016; 11(9):e0161859. PubMed ID: 27583477
    [TBL] [Abstract][Full Text] [Related]  

  • 49. DACT2 silencing by promoter CpG methylation disrupts its regulation of epithelial-to-mesenchymal transition and cytoskeleton reorganization in breast cancer cells.
    Xiang T; Fan Y; Li C; Li L; Ying Y; Mu J; Peng W; Feng Y; Oberst M; Kelly K; Ren G; Tao Q
    Oncotarget; 2016 Oct; 7(43):70924-70935. PubMed ID: 27708215
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Methylation of the gamma-catenin gene is associated with poor prognosis of renal cell carcinoma.
    Breault JE; Shiina H; Igawa M; Ribeiro-Filho LA; Deguchi M; Enokida H; Urakami S; Terashima M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):557-64. PubMed ID: 15701841
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reduced expression of SOX7 in ovarian cancer: a novel tumor suppressor through the Wnt/β-catenin signaling pathway.
    Liu H; Yan ZQ; Li B; Yin SY; Sun Q; Kou JJ; Ye D; Ferns K; Liu HY; Liu SL
    J Ovarian Res; 2014 Sep; 7():87. PubMed ID: 25297608
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Aberrant methylation of tumor suppressor genes in renal cell carcinoma].
    Zhang Q; Jin J; Tao Q
    Ai Zheng; 2007 Nov; 26(11):1276-80. PubMed ID: 17991333
    [TBL] [Abstract][Full Text] [Related]  

  • 53. miR-206 inhibits renal cell cancer growth by targeting GAK.
    Wei C; Wang S; Ye ZQ; Chen ZQ
    J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):852-858. PubMed ID: 27924503
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma.
    Dahl E; Wiesmann F; Woenckhaus M; Stoehr R; Wild PJ; Veeck J; Knüchel R; Klopocki E; Sauter G; Simon R; Wieland WF; Walter B; Denzinger S; Hartmann A; Hammerschmied CG
    Oncogene; 2007 Aug; 26(38):5680-91. PubMed ID: 17353908
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interleukin 6 induces cell proliferation of clear cell renal cell carcinoma by suppressing hepaCAM via the STAT3-dependent up-regulation of DNMT1 or DNMT3b.
    Quan Z; He Y; Luo C; Xia Y; Zhao Y; Liu N; Wu X
    Cell Signal; 2017 Apr; 32():48-58. PubMed ID: 28093267
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genome-wide promoter methylome of small renal masses.
    Ibragimova I; Slifker MJ; Maradeo ME; Banumathy G; Dulaimi E; Uzzo RG; Cairns P
    PLoS One; 2013; 8(10):e77309. PubMed ID: 24204800
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protocadherin20 Acts as a Tumor Suppressor Gene: Epigenetic Inactivation in Nasopharyngeal Carcinoma.
    Chen T; Long B; Ren G; Xiang T; Li L; Wang Z; He Y; Zeng Q; Hong S; Hu G
    J Cell Biochem; 2015 Aug; 116(8):1766-75. PubMed ID: 25736877
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Methylation-associated silencing of TU3A in human cancers.
    Awakura Y; Nakamura E; Ito N; Kamoto T; Ogawa O
    Int J Oncol; 2008 Oct; 33(4):893-9. PubMed ID: 18813805
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protocadherin 17 functions as a tumor suppressor suppressing Wnt/β-catenin signaling and cell metastasis and is frequently methylated in breast cancer.
    Yin X; Xiang T; Mu J; Mao H; Li L; Huang X; Li C; Feng Y; Luo X; Wei Y; Peng W; Ren G; Tao Q
    Oncotarget; 2016 Aug; 7(32):51720-51732. PubMed ID: 27351130
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aberrant promoter methylation of DLEC1, a critical 3p22 tumor suppressor for renal cell carcinoma, is associated with more advanced tumor stage.
    Zhang Q; Ying J; Li J; Fan Y; Poon FF; Ng KM; Tao Q; Jin J
    J Urol; 2010 Aug; 184(2):731-7. PubMed ID: 20639048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.